427 filings
Page 3 of 22
S-3
NAOV
NanoVibronix Inc
Shelf registration
12 Sep 23
4:15pm
8-K
NAOV
NanoVibronix Inc
6 Sep 23
NanoVibronix Announces Presentation of Positive Independent Testing Results of UroShield at ICS Annual Meeting
8:30am
8-K
NAOV
NanoVibronix Inc
1 Sep 23
NanoVibronix Announces $5 Million Private Placement Priced At-The-Market Under Nasdaq Rules
4:30pm
8-K
NAOV
NanoVibronix Inc
30 Aug 23
NanoVibronix Cites Positive Results from Independent Testing of UroShield
8:30am
8-K
NAOV
NanoVibronix Inc
29 Aug 23
Regulation FD Disclosure
4:05pm
8-K
NAOV
NanoVibronix Inc
28 Aug 23
NanoVibronix Applies for Inclusion of UroShield Products in NHS Prescription Services’ Drug Tariff
8:30am
8-K
NAOV
NanoVibronix Inc
23 Aug 23
NanoVibronix Extends Distribution Agreement with Its Largest Distributor for PainShield and PainShield Plus
4:45pm
EFFECT
NAOV
NanoVibronix Inc
14 Aug 23
Notice of effectiveness
12:15am
10-Q
2023 Q2
NAOV
NanoVibronix Inc
Quarterly report
11 Aug 23
5:20pm
CORRESP
NAOV
NanoVibronix Inc
9 Aug 23
Correspondence with SEC
12:00am
UPLOAD
NAOV
NanoVibronix Inc
9 Aug 23
Letter from SEC
12:00am
S-1/A
NAOV
NanoVibronix Inc
IPO registration (amended)
7 Aug 23
5:14pm
S-3
NAOV
NanoVibronix Inc
Shelf registration
1 Aug 23
4:30pm
8-K
NAOV
NanoVibronix Inc
20 Jul 23
Other Events
4:45pm
S-1
NAOV
NanoVibronix Inc
IPO registration
17 Jul 23
5:01pm
8-K
NAOV
NanoVibronix Inc
21 Jun 23
Submission of Matters to a Vote of Security Holders
5:00pm
8-K
NAOV
NanoVibronix Inc
14 Jun 23
NanoVibronix Announces Distribution Agreement with Sports Medicine Supplier Mio-Guard
8:30am
8-K
NAOV
NanoVibronix Inc
25 May 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:30pm
DEFA14A
NAOV
NanoVibronix Inc
18 May 23
Additional proxy soliciting materials
8:32am
8-K
NAOV
NanoVibronix Inc
18 May 23
NanoVibronix Issues Letter to Shareholders
8:30am